Emcure Pharmaceuticals Limited has made a regulatory disclosure pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations.
The Nomination and Remuneration Committee of the Board of Directors approved the allotment of equity shares through Resolution by Circulation (No. 04 of 2026-27) passed on September 11, 2026.
The company allotted 11,400 (Eleven Thousand Four Hundred) Equity Shares of ₹10 each to eligible employees pursuant to the Emcure - Employee Stock Option Scheme 2013 (Emcure ESOS 2013). This allotment was made upon exercise of 11,400 vested options.
Consequent to this allotment, the issued and paid-up share capital of the company has increased as follows:
- From: 18,96,99,247 Equity Shares of ₹10 each, aggregating to ₹1,89,69,92,470
- To: 18,97,10,647 Equity Shares of ₹10 each, aggregating to ₹1,89,71,06,470
The newly allotted Equity Shares will rank pari passu in all aspects with the existing Equity Shares of the company.
The disclosure was signed by Amruta Amit Yangalwar, Company Secretary and Compliance Officer (Membership No.: A25687) on September 11, 2026.